Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol21 October 2021Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.
Dr Colin Western, 1957 - 20217 October 2021Dr Colin Western, Reader in Chemistry, died on 21st September 2021. Professors Andrew Orr-Ewing and Mike Ashfold offer this appreciation.
Major advance in race for SARS-CoV-2 inhibitor drugs30 September 2021A new advance towards the development of drugs specifically designed to inhibit a key SARS-CoV-2 enzyme is reported in the Royal Society of Chemistry's leading journal, Chemical Science. The international team, led by scientists from the Universities of Oxford and Bristol, has designed new peptide molecules and shown that they block (inhibit) the virus’s main protease [Mpro] - a prominent SARS-CoV-2 drug target.
Understanding enzyme evolution paves the way for green chemistry15 September 2021Researchers from the School of Chemistry, University of Bristol have shown how laboratory evolution can give rise to highly efficient enzymes for new-to-nature reactions, opening the door for novel and more environmentally friendly ways to make drugs and other chemicals.
Decline in CO2 cooled earth’s climate over 30 million years ago, scientists find15 September 2021New research led by the School of Chemistry, University of Bristol demonstrates that a decline in the concentration of atmospheric CO2 played a major role in driving Earth’s climate from a warm greenhouse into a cold icehouse world around 34 million years ago. This transition could be partly reversed in the next centuries due to the anthropogenic rise in CO2.
Protocells spring into action25 June 2021A University of Bristol-led team of international scientists with an interest in protoliving technologies, has today published research which paves the way to building new semi-autonomous devices with potential applications in miniaturized soft robotics, microscale sensing and bioengineering.
EPSRC Programme Grant8 June 2021Professor Andrew Orr-Ewing and Dr Tom Oliver, both from the School of Chemistry, have been awarded a 6-year, £7.9M Programme Grant by EPSRC entitled 'Ultrafast Photochemical Dynamics in Complex Environments', together with co-investigators from UCL, Imperial College, Oxford, and Durham.